Pulmonary Function Testing Market Size, Share & Trends Analysis Report By Product (Portable PFT Systems, Complete PFT Systems, Other), By Applications (Hospitals, Physical Examination Center, Physician Groups, Others), By End Use, By Region, and Segment Forecasts - 2035

PULMONARY FUNCTION TESTING MARKET OVERVIEW

The pulmonary function testing market was valued at USD 433.45 million in 2025, The market is set to reach USD 451.65 million by 2026-end and grow at a CAGR of 4.2% between 2026-2035 to reach USD 510.99 million by 2035.

Pulmonary Function Testing (PFT) Systems are instruments that are used to assess the lung functioning capabilities. Such systems are useful in determining various parameters of thoracic health and its volition assisting the physicians to identify and manage the breathing diseases like asthma, chronic obstructive pulmonary diseases (COPD) and other lung related illnesses.

There are various factors driving the Pulmonary Function Testing System Market growth such as, rising prevalence of respiratory disorders and technological advancements in PFT systems. The market will constantly change thanks to the transition to digital health and mobility, thus providing opportunities for both old and new players to create more convenient and multifunctional tools for diagnostics.

• • 

    Download Free sample to learn more about this report.

KEY FINDINGS

• Market Size and Growth: The Pulmonary Function Testing Market size was USD 415.97 Million in 2024, is projected to grow to USD 432.28 Million by 2025 and exceed USD 470.62 Million by 2033, with a CAGR of 4.2%.

• Key Market Driver: With over 390 million people globally affected by chronic respiratory diseases like COPD and asthma, the demand for spirometry-based lung function testing saw a 17% rise in hospitals and diagnostic labs in 2023.

• Major Market Restraint: Nearly 29% of small clinics in low-income regions lack access to standardized pulmonary diagnostic tools due to limited technician training and device costs.

• Emerging Trends: Portable PFT devices are having their moment. In 2023, sales of handheld spirometers increased by 21%, especially among telehealth-integrated respiratory care providers.

• Regional Leadership: North America led usage in 2023, contributing nearly 44% of total procedural volume, with the U.S. alone accounting for more than 22 million tests performed that year.

• Competitive Landscape: Around 40 companies are active globally, but just six of them—like MGC Diagnostics and Vyaire Medical—hold over 60% of the device-based testing segment.

• Market Segmentation: Spirometry devices represented close to 53% of total device sales in 2023, followed by plethysmography systems used mostly in advanced pulmonary care units.

• Recent Development: In late 2023, NDD Medical Technologies launched a new Bluetooth-enabled spirometer that reduced test time by 35%, aiming to increase throughput in high-volume clinics.

COVID-19 IMPACT

"Increased Demand for Respiratory Health Assessment During Covid Resulted in Huge Demand"

The Global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

Increased demand for Pulmonary Function Testing (PFT) systems was particularly observed during the COVID-19 epidemic as respiratory health became a centre of attention. With lungs being the most affected by COVID-19, there arose a growing need for devices to evaluate lung function in patients who were both acutely sick or recuperating. The need for PFTs among many imposed for use especially for monitoring the lung health after an infection, was specifically high for those with persistent symptoms. This increase highlighted the need for respiratory diagnostics, which in turn paradoxically enabled providers of PFT systems to grow and invent owing to an upsurge in the need for solutions that facilitate assessment and monitoring of lung health.

LATEST TREND

"Including Software for Enhanced Data Analysis and Remote Monitoring to Drive Market Growth"

The Market for Pulmonary Function Testing (PFT) Systems has been witnessing a trend where advanced software has been incorporated in order to improve data analysis and remote observation. Inasmuch software permits the application of sophisticated analysis such as lung function in real time and encourages telehealth so that patients can be reviewed without being in the same facility as the clinicians. The advanced analysis gives more insight into the health status of a person and their ability to control the breathing patterns which aids in the prevention and control of chronic conditions. Built by bringing these things together, the chronic respiratory disease patient population will increase during the forecast period as more will have access and will be able to use easy and effective ways of treating their respiratory conditions.

• • 

    Download Free sample to learn more about this report.

PULMONARY FUNCTION TESTING MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Portable PFT Systems & Complete PFT Systems

• Portable PFT Systems: Portable PFT systems have been built while keeping mobility and convenience in mind. They are lightweight and easily transportable which makes them well-suited for bedside testing, as well as home care and off-site examinations. Such systems are beneficial for patients who require regular check- ups or those who are unable to get to the hospital easily.

• Complete PFT Systems: All-function or complete PFT systems include a wide range of diagnostic tests such as spirometry, lung volumes, and diffusion capacity tests. This is mostly found in hospitals, special treatment units, and researchers’ institutions.

By Application

Based on application, the global market can be categorized into Hospitals, Physical Examination Center, Physician Groups & Others

• Hospitals: The use of procedures functional testing systems (PFT) among hospitals is very common for inpatient and outpatient services. These systems are of fundamental importance in the treatment and rehabilitation of acute and chronic respiratory diseases, especially in critical care and patients with advanced pulmonary ailments.

• Physical Examination Center: PFT systems are widely used in physical examination centres to assess lung function during routine health screenings. This helps in early detection of respiratory issues and monitoring the impact of environmental factors, occupational exposure, or lifestyle on lung health.

• Physician Groups: Less comprehensive physician practices, particularly those that cater to patients’ respiratory problems, use PFT systems in order to provide easy options for diagnostic testing. The portable PFT system is ideal in this case owing to its low-cost and easily accessible features for evaluating patients on a regular basis.

• Others: This category includes use cases such as research institutes, sports medicine, rehabilitation centres, and at-home healthcare.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

"Rising Prevalence of Respiratory Disorders to Boost the Market"

A factor in the Pulmonary Function Testing System Market growth is the rising prevalence of respiratory disorders. Over the past year, there has been a surge in the worldwide occurrences of respiratory diseases such as asthma and chronic obstructive pulmonary diseases and pulmonary fibrosis etc. These factors have resulted in the increased demand for effective methods of diagnosis and treatment of such diseases. In addition, factors such as air pollution, smoking and occupational exposure to certain toxic materials contribute to the breathing complications which popularised the use of PFT systems. This comes in handy when providing medical attention to the patients with respiratory disorders.

"Technological Advancements in PFT Systems to Expand the Market"

The technological advancements in PFT systems is another key aspect of the Pulmonary Function Testing System Market. The contemporary pulmonary function testing (PFT) systems today has incorporated most of the elements of digital connectivity, sophisticated data analysis, and usage of cloud-based systems, which enable more accurate testing of respiratory functions in real time. Such changes encourage the use of remote surveillance and telehealth in the management of the patient because, for instance, the doctor is able to monitor the lung functions of the patients from a distance. Also, with sensor technologies getting better provides enhanced and detailed lung measurements, which helps to detect the disease earlier and control it better.

Restraining Factor

"Require Trained Technicians to Operate and Interpret the Results to Potentially Impede Market Growth"

A restraining element within the growth of the Pulmonary Function Testing System Market is the need for trained technicians to operate and interpret the results. PFT systems incorporate a complex set of procedures and produce large amounts of data which require a high level of expertise for satisfactory interpretation. This fact limits the use of PFT systems in regions with a dearth of skilled health professionals. Furthermore, training and certification are often expensive and take time limiting smaller health care facilities from accessing these crucial diagnostic tools.

Opportunity

"Portable and Home-Use Devices To Create Opportunity for the Product in the Market"

The increasing demand for portable and home-based pulmonary function testing (PFT) devices offers immense growth potential in the market. These devices enable the patients to take care of their respiratory health by themselves at their homes which is more beneficial to patients suffering from chronic respiratory illnesses like asthma or chronic obstructive pulmonary disease. The handheld PFT systems that are patient-oriented are basic in nature and can be fitted in a telemedicine system where the patient’s condition is monitored by the health care provider remotely and data is sent in real time. This bolsters market growth as there is also a rise in the demand commercialization of nursed out services.

Challenge

"High Cost of PFT System Could Be a Potential Challenge for Consumers"

Consumer demand, especially from smaller healthcare facilities and individual users, is challenged by the sky-high prices of pulmonary function testing (PFT) systems. Most of these advanced PFT systems with full diagnostic capabilities are quite costly making them not readily available to resource poor hospitals, clinics, and homes. In addition, there are further expenses incurred in maintenance and calibration and even additional software upgrades. Such a financial handicap may serve as a negative impetus for the development of the market.

• • 

    Download Free sampleto learn more about this report.

•  

PULMONARY FUNCTION TESTING MARKET REGIONAL INSIGHTS

North America

The PFT systems market is dominated by North America due to numerous respiratory comorbidities, advanced medical care management, and advanced treatment techniques. In the United States Pulmonary Function Testing System Market is expanding due to factors, such as government funding initiatives for respiratory health, prevalent chronic respiratory diseases such as asthma and COPD. In addition, the characteristics of the region also facilitated growth in the market due to the presence of several major players in the region as well as growing telemedicine and home healthcare trends in the region.

Europe

The European market for PFT systems is significant as a result of the regional ageing population and rising respiratory health awareness. Nations like Germany, the U.K., and France possess a robust health care infrastructure coupled with a high need for equipment used in the diagnosis of lung diseases given the rising levels of air pollution. In addition to this, the market in Europe is also helped by the respiratory management policy by governments and availability of sophisticated healthcare systems.

Asia

One of the contributing factors fuelling the increase in the PFT systems market in Asia is the increase in the cases of respiratory diseases, urbanisation and pollution, together with the increased use of tobacco. Major markets include China, India and Japan, which are witnessing rapid improvements in healthcare infrastructure and availability of diagnostics. Also, the establishment of healthcare facilities and the rising emphasis on control of chronic conditions are other factors that augment the growth of the market.

KEY INDUSTRY PLAYERS

"Key Industry Players Shaping the Market Through Innovation and Market Expansion"

The growing demand for pulmonary function testing (PFT) systems in the market has been as a result of several innovations and expansions by key players in the industry. PFT systems are being advanced to incorporate features aimed at improving the digital aspect of such systems as enclosing cloud facilities and remote monitoring with the aim of improving diagnosis and access. Besides market expansion into developing countries, major players are also funding research to design affordable and skinnable devices that meet the different healthcare needs. Their cooperation with various hospitals and research institutes strengthens their position in this regard.

LIST OF TOP PULMONARY FUNCTION TESTING COMPANIES

• CareFusion (BD) (U.S.)
• Schiller (Switzerland)
• CHEST (Japan)
• COSMED (Italy)
• nSpire Health (U.S.)
• NDD (Switzerland)
• MGC Diagnostics (U.S.)
• Minato (Japan)
• Ganshorn (Germany)
• AESRI (China)
• Morgan Scientific (U.S.)
• M&B (China)
• Sikeda (China)
• RSDQ (China)

KEY INDUSTRY DEVELOPMENT

April 2024: Clario's acquisition of ArtiQ enhances its Respiratory Solutions portfolio by integrating advanced AI capabilities. This strategic move combines Clario's expertise with ArtiQ’s innovative technology to improve test quality and accelerate data processing in clinical trials. The acquisition, alongside Inofab Health, solidifies Clario's leadership in respiratory care and broadens its AI-driven clinical solutions.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The Pulmonary Function Testing System Market is poised for a continued boom pushed by rising prevalence of respiratory disorders and technological advancements in PFT systems. Despite challenges, which include the high cost of the PFT system. Key industry players are advancing via technological upgrades and strategic marketplace growth, enhancing the supply and attraction of pulmonary function testing systems. As customer choices shift towards portable options, the Pulmonary Function Testing System Market is expected to thrive, with persistent innovation and a broader reputation fueling its destiny prospects.